← Open Payments lookup

SHEILA WATSON: Open Payments

NPI 1043614035 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$321 in 15 payments from 11 companies in 2025. Trend: 2023 $688 · 2024 $659 · 2025 $321

Food & beverage: $321
CompanyPaymentsAmount
Gilead Sciences, Inc.1$80
ABBVIE INC.2$47
Novo Nordisk Inc2$39
AstraZeneca Pharmaceuticals LP2$30
Phathom Pharmaceuticals, Inc.2$23
Bayer Healthcare Pharmaceuticals Inc.1$22
Otsuka America Pharmaceutical, Inc.1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
Dexcom, Inc.1$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15

Products named: BREZTRI, VRAYLAR, VOQUEZNA, Kerendia, Wegovy, REXULTI, QULIPTA, Ozempic.

Industry payments across IN — which companies pay providers there.